MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 69 filers reported holding MEREO BIOPHARMA GROUP PLC in Q1 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4,692,572 | +562.8% | 3,554,979 | +1114.6% | 0.03% | +800.0% |
Q3 2021 | $708,000 | -90.9% | 292,692 | -88.1% | 0.00% | -91.2% |
Q2 2021 | $7,796,000 | -65.6% | 2,459,399 | -63.4% | 0.03% | -65.3% |
Q1 2021 | $22,646,000 | +4.9% | 6,719,948 | +11.4% | 0.10% | +21.0% |
Q4 2020 | $21,588,000 | – | 6,030,293 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,972,958 | $4,775,000 | 1.26% |
Altium Capital Management LP | 1,250,000 | $3,025,000 | 0.79% |
Rubric Capital Management LP | 11,300,000 | $27,346,000 | 0.76% |
Vivo Capital, LLC | 6,907,189 | $16,715,000 | 0.75% |
DAFNA Capital Management LLC | 1,126,613 | $2,726,000 | 0.72% |
SILVERARC CAPITAL MANAGEMENT, LLC | 365,661 | $885,000 | 0.50% |
Orbimed Advisors | 17,264,764 | $41,781,000 | 0.46% |
Delphi Management Partners VIII, L.L.C. | 256,734 | $621,000 | 0.45% |
Endurant Capital Management LP | 746,514 | $1,807,000 | 0.41% |
Affinity Asset Advisors, LLC | 650,000 | $1,573,000 | 0.40% |